Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.
- DOI
- 10.1016/j.ophtha.2019.11.018
- Published
- 2020 May
- Container
- Ophthalmology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ophtha.2019.11.018,
title = {Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.},
author = {Bhandari S and Nguyen V and Fraser-Bell S and Mehta H and Viola F and Baudin F and Gabrielle PH and Creuzot-Garcher C and Gillies M and Barthelmes D},
year = {2020},
journal = {Ophthalmology},
doi = {10.1016/j.ophtha.2019.11.018},
url = {https://doi.org/10.1016/j.ophtha.2019.11.018}
}RIS
TY - JOUR TI - Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry. AU - Bhandari S AU - Nguyen V AU - Fraser-Bell S AU - Mehta H AU - Viola F AU - Baudin F AU - Gabrielle PH AU - Creuzot-Garcher C AU - Gillies M AU - Barthelmes D PY - 2020 JO - Ophthalmology DO - 10.1016/j.ophtha.2019.11.018 UR - https://doi.org/10.1016/j.ophtha.2019.11.018 ER -
APA
S, B., V, N., S, F., H, M., F, V., F, B., PH, G., C, C., M, G., & D, B. (2020). Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.. Ophthalmology. https://doi.org/10.1016/j.ophtha.2019.11.018
Source records
- pubmed · retrieved 2026-09-25T23:46:50.390Z